Please assess the completion status of the following clinical trial:

Trial Title: Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient receiving hemodialysis at a DaVita clinic/dialysis center~* Receiving in-center hemodialysis thrice weekly~* Central venous catheter (CVC) use for \> 180 days~* Patients report a fear of needles as a top-3-reason for failure to get an arteriovenous fistula/graft~Exclusion Criteria:~* Patients have a known intolerance or hypersensitivity to Synera~* Patient with a history of or past diagnosis of severe hepatic disease~* Patient is currently receiving any class 1 antiarrhythmic drugs (i.e., tocainide, mexiletine, etc)~* Patient has a clinically significant illness within 14 days of Screening/Day 1 that, in the opinion of the investigator, would preclude the subject from participating in the study~* Patient has an AVF or AVG in place or is scheduled for placement~* Women and men whose partners are of childbearing potential (defined as premenopausal and not surgically sterilized \[ie, bilateral tubal ligation, bilateral oophorectomy, or hysterectomy\] or postmenopausal for \< 2 years) agree to practice 1 of the following medically acceptable methods of birth control and agree to continue with the regimen throughout the duration of the study: Oral, implantable, or injectable contraceptives for 3 consecutive months before the Screening Visit; Intrauterine device (IUD); and double barrier method (ie, condom, sponge, diaphragm, or vaginal ring with spermicidal jellies or cream)~* Patient has significant disease or condition that, in the PI's opinion, may interfere with protocol adherence or subjects' ability to provide informed consent~* Patient is unable to read or comprehend English at a 6th grade level~* Patient has a visual impairment and is unable to read the survey instruments~* Patient has a suspected or known access-related infection at the time of enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Enhanced Needle Phobia Intervention (Type: EXPERIMENTAL): Patients will receive enhanced needle phobia intervention comprising the standard intervention plus demonstration of Synera
- Standard Needle Phobia Intervention (Type: ACTIVE_COMPARATOR): Patients will receive the standard intervention for needle phobia

Based on this trial design, predict the completion outcome and termination type (if applicable).